Editek

Moves to trading on the Primary Market of the American Stock Exchange Sept. 24 under the symbol "EDI." The firm met listing requirements through recent private placements of approximately $1 mil. The Burlington, North Carolina firm, which had traded on the Emerging Company Marketplace, recently signed a letter of intent to acquire drug testing firm PDLA.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight